Terms of Access and Use

By downloading, accessing, or viewing material from this website, you agree to the following Terms of Use. The research and analysis provided by Forensic Alpha Limited (“we”, “us”) is for informational and educational purposes only and does not constitute investment advice, a recommendation to buy, sell, or hold any security, or any other form of regulated advice. We do not have, and do not seek to establish, any position (long or short) in the securities discussed in our research.

Our reports present our independent opinions on publicly available information, including but not limited to, company disclosures and financial statements. We aim to highlight potential risks, governance issues, or accounting practices that we believe merit further consideration by market participants. You agree to conduct your own research and due diligence, and to consult your own financial, legal, tax, and other professional advisers before making any investment or business decision. Use of our research is entirely at your own risk. In no event shall Forensic Alpha Limited or any affiliated party be liable for any direct, indirect, incidental, or consequential losses arising from your use of our materials.

The information we provide is based on sources we believe to be accurate and reliable at the time of publication, but it is provided “as is” without any representation or warranty of any kind, whether express or implied, including without limitation as to accuracy, completeness, or fitness for any particular purpose. All opinions expressed are subject to change without notice, and we do not undertake to update or supplement our research.

Access to our research is intended only for persons who are professional investors, institutional investors, or otherwise qualified to receive such information under applicable laws in their jurisdiction. In the United Kingdom, this includes (but is not limited to) persons falling within one or more of the categories described in Articles 19 (Investment Professionals) and 49 (High Net Worth Companies, Unincorporated Associations etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. By proceeding to access our materials, you confirm that you meet the relevant criteria in your jurisdiction and are legally permitted to receive such information.

All content on this site is the intellectual property of Forensic Alpha Limited and is protected by applicable copyright laws. You agree not to reproduce, distribute, or transmit our research, in whole or in part, without our prior written consent, except by sharing a direct link to our website.

By clicking “I Agree” below, you confirm that you have read and agree to Forensic Alpha Limited’s Terms of Access and Use, that you are a professional or institutional investor (or otherwise qualified under the laws of your jurisdiction to receive such information), and that you understand our research does not constitute investment advice or a recommendation to buy, sell, or hold any security.
I Agree
back arrow

Rivian Automotive: Stalling Speed

Thomas Beevers
Thomas Beevers
May 13, 2026
Copied!
share button icon

Rivian Automotive: Stalling Speed

Judging by the level of short interest, it seems there is already plenty of bearish sentiment on this stock, much of it related to weakening demand and cash outflows. Looking purely through our forensic lens, we see additional concerns mounting in the 10-Q filing, pushing the stock up to a risk rating of ‘9/10’ on our system.

Key among these is the sharp increase in finished goods inventory, which we can observe in the 10-Q disclosure below. We see a 67% increase in finished goods inventory in the space of just 3 months to nearly $1.5bn. The percentage weighting of finished goods within inventory (56%) is now far higher than the normal 30-40% range seen in previous quarters.

The increase is a function of the fact that Rivian produced 14,611 vehicles in Q1 but only delivered 8,640 vehicles. Management were open about the level of over-production on the analyst call, and it was framed as an intentional increase in order to manage the planned facility closure in the second half:

“we had produced more vehicles than we delivered in Q1 to help offset some of the lost production in the back half of the year as we shut down our manufacturing facility for roughly a month to integrate R2 into the plant.”

Claire Rauh McDonough, CFO

However, note that the guidance on deliveries was downgraded after the end of the quarter. As at April 2, when Rivian released production and delivery numbers, the company was still expecting deliveries in 2025 of 46k - 51k. However 1 month later (May 6), this was downgraded to a range of 40-46k.  This suggests a risk that Rivian is carrying too much inventory based on expected deliveries for the rest of the year (even accounting for the one month shut-down) and will have to reduce the rate of production significantly to clear the excess inventory.

This matters because COGS per unit ultimately depends on the level of production. When production is high, fixed costs are spread across more units, benefitting the gross margin. Over the past 3 quarters, production has been relatively high (an average of 13,500 per quarter), which is helping to keep COGS/unit low.  This was one of the factors that allowed Rivian to generate a second consecutive quarter of gross profit in Q1 and in the process unlock $1bn of funding from VW (see quote below from the Q1 call - our emphasis added)

“the key driver for us in Q1 [of per unit improvement in COGS] was predominantly driven by some of the improvements that we've made in operational efficiency as well as the fixed cost leverage that we had in the quarter given the higher production volumes with just over 14,600 units produced as a whole”

Claire Rauh McDonough, CFO

However when production falls, those same fixed costs must be spread across fewer units and COGS/unit is likely to increase.  Based on the mid-point of guidance (43k for 2025), deliveries for the last 3 quarters of the year will average around 11,500 units per quarter.  Even accounting for the 1 month shut-down this implies that the normalized production rate must come down just to keep finished goods inventory steady.

Lower production in the coming quarters would represent a headwind for margins, potentially reversing some of the progress made in the past 2 quarters.  In addition, investors should be aware that the longer excess inventory sits on the balance sheet the greater the risk of obsolescence (particularly in the fast moving market for EVs). As in previous quarters, Rivian may be required to take write-downs on the value of inventory where they find they cannot sell it above cost.

If you are an institutional investor, you can sign up to our email list here
arrow icon
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Institutional investors are eligible for a 7-day free trial.

Our machine intelligence helps Portfolio Managers to spot critical red flags hidden deep within the financial statements and governance disclosures.

Request Demo

Forensic Alpha uses proprietary machine intelligence to identify risks hidden deep within the financial statements and governance disclosures.

Forensic Alpha Limited
Level 39, One Canada Square
Canary Wharf
London E14 5AB

Forensic Alpha US INC
12 East 49th Street
New York
NY 10017
USA

forensic alpha
Forensic Alpha Limited
Level 39, One Canada Square
Canary Wharf
London E14 5AB
Forensic Alpha US INC
12 East 49th Street
New York NY 10017
USA
Forensic Alpha Limited is authorised and regulated by the Financial Conduct Authority (Reference number: 763770)
© 2022 Forensic Alpha. All rights reserved.  Terms & Conditions  |  Privacy Policy  |  Cookie policy
twitter profilelinkedin profile